Patents by Inventor Hugo Van Heuverswijn

Hugo Van Heuverswijn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 6872520
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: March 29, 2005
    Assignee: Innogenetics N.V.
    Inventors: Robert J. DeLeys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Publication number: 20050003345
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Application
    Filed: April 13, 2004
    Publication date: January 6, 2005
    Applicant: INNOGENETICS, S.A.
    Inventors: Robert Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 6576417
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: June 10, 2003
    Assignee: Innogenetics, N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Publication number: 20020106640
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Application
    Filed: August 30, 2001
    Publication date: August 8, 2002
    Applicant: Innogenetics N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 6287761
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: September 11, 2001
    Assignee: Innogenetics N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 6007982
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 28, 1999
    Assignee: Innogenetics N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 5922532
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: July 13, 1999
    Assignee: Innogenetics, N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn
  • Synthetic antigens for the detection of antibodies to hepatitis C virus
    Patent number: 5910404
    Abstract: Peptide sequences are provided which are capable of mimicking proteins encoded by HCV for use as reagents for screening of blood and blood products for prior exposure to HCV. The peptides are at least 5 amino acids long and can be used in various specific assays for the detection of antibodies to HCV, for the detection of HCV antigens, or as immunogens.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: June 8, 1999
    Assignee: Innogenetics N.V.
    Inventors: Robert J. Deleys, Dirk Pollet, Geert Maertens, Hugo Van Heuverswijn